The Global Hemostasis/Coagulation Analyzers Market 2018-2026 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 18, 2018--The “Global Hemostasis/Coagulation Analyzers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.
The global hemostasis/coagulation analyzers market was valued at US$ 3,650.1 Mn in 2017 and expected to reach US$ 9,548 Mn by 2026, expanding at a CAGR of 9.9% from 2018 to 2026.
Growing incidence of blood disorders is mainly attributed to the growth of hemostasis analyzers market. Perpetual innovation in technology and miniaturization has led to commercialization of many novel devices that have quick turnaround time and also can be used in point of care settings. Furthermore, growing awareness and demand for technologically advanced medical treatments, support from governments and growing adoption of laboratory automation urges the demand for novel coagulation analyzers.
Among the test types, routine coagulation tests occupy the largest share of the global market. A large number of these tests being performed for almost all surgical procedures and treatments mainly assists in the dominance of this segment. Growing adoption of specific tests such as VWF assays and thrombophilia testing in the light of growing awareness and prevalence of coagulation disorders will facilitate faster growth rate to diagnostic hemostasis assays segment. Currently, between devices (analyzers) and consumables, the former segment holds larger revenue share globally. Higher cost and consistently growing purchase of these systems both in laboratory and point of care settings are attributed to the prominence of devices segment.
Based on end users, the diagnostic laboratories segment dominated the global market. Greater preference of analyzing samples in specialized laboratories mainly drives this segment. The uptake of hemostasis analyzers is high in research institutions due to the surge in the number of clinical trials being undertaken for treatment development and innovating diagnostic solutions.
Key HighlightsGrowing incidence of hematological diseases and increasing preference for coagulation tests in all surgical procedures The rapid evolution of healthcare infrastructure in untapped markets of Asia Pacific Growing preference for novel compact and automatic analyzers that can be used in point of care settings Growing efforts to commercialize novel drugs for the treatment of coagulation disorders Rapid penetration of major market players in the emerging regions and Asia Pacific, parts of Latin America and Middle East & Africa
Companies ProfiledAlere Inc. (Abbott Laboratories, Inc.) F-Hoffmann La Roche Sysmex Corporation Beckman Coulter, Inc. (Danaher) Nihon Kohden Corporation Thermo Fisher Scientific Inc. Siemens Healthcare (Siemens AG) International Technidyne Corporation (Werfen) Beckman Coulter Inc.
For more information about this report visit https://www.researchandmarkets.com/research/l8nvh6/the_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180918005476/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Medical Devices
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/18/2018 06:52 AM/DISC: 09/18/2018 06:52 AM